ArticleJournal of metabolic and bariatric surgery2026
Clinical Outcomes of Alternate Laparoscopic Linear Stapler in Primary Sleeve Gastrectomy: A Single-Center Retrospective Study of Safety and Feasibility.
Article in Journal of metabolic and bariatric surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preliminary Safety Evaluation of the Bendos Q Powered Stapling System in Laparoscopic Sleeve Gastrectomy.Journal of metabolic and bariatric surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Staple line bleeding and leak are recognized sources of morbidity in sleeve gastrectomy, with reported rates of 1-5% and 1-3%, respectively. This study evaluated the safety and feasibility of an alternate laparoscopic linear stapling device in primary sleeve gastrectomy. Materials and Methods: We retrospectively reviewed 100 consecutive patients who underwent primary laparoscopic sleeve gastrectomy using an alternate laparoscopic linear stapler (iREACH OMNIA; Reach Surgical, Inc.) between January 2024 and February 2025 at Seoul Medical Center. Patients were stratified by body mass index (BMI) class: Class I (30-34.9 kg/m Results: No staple line complications were observed: staple line bleeding 0% (95% confidence interval [CI], 0-3.7%), leak 0% (95% CI, 0-3.7%), and reoperation 0%. Estimated blood loss was 98.3±42.5 mL (P=0.362) and length of stay 5.1±0.5 days (P=0.758), both uniform across BMI groups. A standardized stapler configuration (1 Black + 4-5 Purple cartridges) was used in over 90% of cases regardless of BMI class. At 1-month follow-up, % total weight loss by group was 11.75±3.35%, 13.42±6.37%, and 13.79±4.27% for Classes I, II, and III, respectively, and % excess weight loss was 49.93%, 41.43%, and 33.41%. Conclusion: The alternate laparoscopic linear stapler demonstrated a favorable safety profile in primary sleeve gastrectomy, with no observed staple line complications across BMI categories. Larger multicenter comparative studies with longer follow-up are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.